The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Montelukast Sodium Chewable Tablets Market Research Report 2024

Global Montelukast Sodium Chewable Tablets Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1743890

No of Pages : 109

Ask Your Query

Synopsis
Montelukast Sodium Chewable Tablets is a selective cysteinyl leukotriene receptor antagonist, mainly used for the prevention and long-term treatment of asthma and to relieve the symptoms of allergic rhinitis, and can also be used for chronic urticaria and children with non-severe diseases such as obstructive sleep apnea.

Global Montelukast Sodium Chewable Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Montelukast Sodium Chewable Tablets market research.

Key manufacturers engaged in the Montelukast Sodium Chewable Tablets industry include Organon, Merck, Teva Pharmaceuticals, Sandoz, Mylan N.V., GSK, Pfizer, Yangtze River Pharmaceutical (Group) Co., Ltd. and Beijing Foyou Pharma CO.,Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Montelukast Sodium Chewable Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Montelukast Sodium Chewable Tablets market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Montelukast Sodium Chewable Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Organon
  • Merck
  • Teva Pharmaceuticals
  • Sandoz
  • Mylan N.V.
  • GSK
  • Pfizer
  • Yangtze River Pharmaceutical (Group) Co., Ltd.
  • Beijing Foyou Pharma CO.,Ltd.
  • Nanjing Hicin Pharmaceutical Co., Ltd.
  • Zhejiang Nuode Pharmaceutical Co., Ltd.
  • Hefei Yingtai Pharmaceutical Co., Ltd.
  • Lunan Better Pharmaceutical Co., Ltd.
  • Sichuan Otsuka Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical (Hainan) Co., Ltd.
  • Cspc Ouyi Pharmaceutical Co., Ltd.

Segment by Type

  • 4mg/tablet
  • 5mg/tablet

Segment by Application

  • Hospital
  • Clinic
  • Retail Pharmacy
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Montelukast Sodium Chewable Tablets report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Montelukast Sodium Chewable Tablets Market Overview
1.1 Product Overview and Scope of Montelukast Sodium Chewable Tablets
1.2 Montelukast Sodium Chewable Tablets Segment by Type
1.2.1 Global Montelukast Sodium Chewable Tablets Market Value Comparison by Type (2023-2029)
1.2.2 4mg/tablet
1.2.3 5mg/tablet
1.3 Montelukast Sodium Chewable Tablets Segment by Application
1.3.1 Global Montelukast Sodium Chewable Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Retail Pharmacy
1.3.5 Others
1.4 Global Montelukast Sodium Chewable Tablets Market Size Estimates and Forecasts
1.4.1 Global Montelukast Sodium Chewable Tablets Revenue 2018-2029
1.4.2 Global Montelukast Sodium Chewable Tablets Sales 2018-2029
1.4.3 Global Montelukast Sodium Chewable Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Montelukast Sodium Chewable Tablets Market Competition by Manufacturers
2.1 Global Montelukast Sodium Chewable Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Montelukast Sodium Chewable Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Montelukast Sodium Chewable Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Montelukast Sodium Chewable Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Montelukast Sodium Chewable Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Montelukast Sodium Chewable Tablets, Product Type & Application
2.7 Montelukast Sodium Chewable Tablets Market Competitive Situation and Trends
2.7.1 Montelukast Sodium Chewable Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Montelukast Sodium Chewable Tablets Players Market Share by Revenue
2.7.3 Global Montelukast Sodium Chewable Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Montelukast Sodium Chewable Tablets Retrospective Market Scenario by Region
3.1 Global Montelukast Sodium Chewable Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Montelukast Sodium Chewable Tablets Global Montelukast Sodium Chewable Tablets Sales by Region: 2018-2029
3.2.1 Global Montelukast Sodium Chewable Tablets Sales by Region: 2018-2023
3.2.2 Global Montelukast Sodium Chewable Tablets Sales by Region: 2024-2029
3.3 Global Montelukast Sodium Chewable Tablets Global Montelukast Sodium Chewable Tablets Revenue by Region: 2018-2029
3.3.1 Global Montelukast Sodium Chewable Tablets Revenue by Region: 2018-2023
3.3.2 Global Montelukast Sodium Chewable Tablets Revenue by Region: 2024-2029
3.4 North America Montelukast Sodium Chewable Tablets Market Facts & Figures by Country
3.4.1 North America Montelukast Sodium Chewable Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Montelukast Sodium Chewable Tablets Sales by Country (2018-2029)
3.4.3 North America Montelukast Sodium Chewable Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Montelukast Sodium Chewable Tablets Market Facts & Figures by Country
3.5.1 Europe Montelukast Sodium Chewable Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Montelukast Sodium Chewable Tablets Sales by Country (2018-2029)
3.5.3 Europe Montelukast Sodium Chewable Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Montelukast Sodium Chewable Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Montelukast Sodium Chewable Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Montelukast Sodium Chewable Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Montelukast Sodium Chewable Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Montelukast Sodium Chewable Tablets Market Facts & Figures by Country
3.7.1 Latin America Montelukast Sodium Chewable Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Montelukast Sodium Chewable Tablets Sales by Country (2018-2029)
3.7.3 Latin America Montelukast Sodium Chewable Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Montelukast Sodium Chewable Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Montelukast Sodium Chewable Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Montelukast Sodium Chewable Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Montelukast Sodium Chewable Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Montelukast Sodium Chewable Tablets Sales by Type (2018-2029)
4.1.1 Global Montelukast Sodium Chewable Tablets Sales by Type (2018-2023)
4.1.2 Global Montelukast Sodium Chewable Tablets Sales by Type (2024-2029)
4.1.3 Global Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2029)
4.2 Global Montelukast Sodium Chewable Tablets Revenue by Type (2018-2029)
4.2.1 Global Montelukast Sodium Chewable Tablets Revenue by Type (2018-2023)
4.2.2 Global Montelukast Sodium Chewable Tablets Revenue by Type (2024-2029)
4.2.3 Global Montelukast Sodium Chewable Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Montelukast Sodium Chewable Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Montelukast Sodium Chewable Tablets Sales by Application (2018-2029)
5.1.1 Global Montelukast Sodium Chewable Tablets Sales by Application (2018-2023)
5.1.2 Global Montelukast Sodium Chewable Tablets Sales by Application (2024-2029)
5.1.3 Global Montelukast Sodium Chewable Tablets Sales Market Share by Application (2018-2029)
5.2 Global Montelukast Sodium Chewable Tablets Revenue by Application (2018-2029)
5.2.1 Global Montelukast Sodium Chewable Tablets Revenue by Application (2018-2023)
5.2.2 Global Montelukast Sodium Chewable Tablets Revenue by Application (2024-2029)
5.2.3 Global Montelukast Sodium Chewable Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Montelukast Sodium Chewable Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Organon
6.1.1 Organon Corporation Information
6.1.2 Organon Description and Business Overview
6.1.3 Organon Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Organon Montelukast Sodium Chewable Tablets Product Portfolio
6.1.5 Organon Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Montelukast Sodium Chewable Tablets Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Teva Pharmaceuticals
6.3.1 Teva Pharmaceuticals Corporation Information
6.3.2 Teva Pharmaceuticals Description and Business Overview
6.3.3 Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Product Portfolio
6.3.5 Teva Pharmaceuticals Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sandoz Montelukast Sodium Chewable Tablets Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Mylan N.V.
6.5.1 Mylan N.V. Corporation Information
6.5.2 Mylan N.V. Description and Business Overview
6.5.3 Mylan N.V. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan N.V. Montelukast Sodium Chewable Tablets Product Portfolio
6.5.5 Mylan N.V. Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GSK Montelukast Sodium Chewable Tablets Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Montelukast Sodium Chewable Tablets Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.8.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.8.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.8.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.8.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.9 Beijing Foyou Pharma CO.,Ltd.
6.9.1 Beijing Foyou Pharma CO.,Ltd. Corporation Information
6.9.2 Beijing Foyou Pharma CO.,Ltd. Description and Business Overview
6.9.3 Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.9.5 Beijing Foyou Pharma CO.,Ltd. Recent Developments/Updates
6.10 Nanjing Hicin Pharmaceutical Co., Ltd.
6.10.1 Nanjing Hicin Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Nanjing Hicin Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.10.5 Nanjing Hicin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Zhejiang Nuode Pharmaceutical Co., Ltd.
6.11.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Corporation Information
6.11.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Description and Business Overview
6.11.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.11.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Hefei Yingtai Pharmaceutical Co., Ltd.
6.12.1 Hefei Yingtai Pharmaceutical Co., Ltd. Corporation Information
6.12.2 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Description and Business Overview
6.12.3 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.12.5 Hefei Yingtai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Lunan Better Pharmaceutical Co., Ltd.
6.13.1 Lunan Better Pharmaceutical Co., Ltd. Corporation Information
6.13.2 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Description and Business Overview
6.13.3 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.13.5 Lunan Better Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Sichuan Otsuka Pharmaceutical Co., Ltd.
6.14.1 Sichuan Otsuka Pharmaceutical Co., Ltd. Corporation Information
6.14.2 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Description and Business Overview
6.14.3 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.14.5 Sichuan Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Qilu Pharmaceutical (Hainan) Co., Ltd.
6.15.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Corporation Information
6.15.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Description and Business Overview
6.15.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.15.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
6.16 Cspc Ouyi Pharmaceutical Co., Ltd.
6.16.1 Cspc Ouyi Pharmaceutical Co., Ltd. Corporation Information
6.16.2 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Description and Business Overview
6.16.3 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolio
6.16.5 Cspc Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Montelukast Sodium Chewable Tablets Industry Chain Analysis
7.2 Montelukast Sodium Chewable Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Montelukast Sodium Chewable Tablets Production Mode & Process
7.4 Montelukast Sodium Chewable Tablets Sales and Marketing
7.4.1 Montelukast Sodium Chewable Tablets Sales Channels
7.4.2 Montelukast Sodium Chewable Tablets Distributors
7.5 Montelukast Sodium Chewable Tablets Customers
8 Montelukast Sodium Chewable Tablets Market Dynamics
8.1 Montelukast Sodium Chewable Tablets Industry Trends
8.2 Montelukast Sodium Chewable Tablets Market Drivers
8.3 Montelukast Sodium Chewable Tablets Market Challenges
8.4 Montelukast Sodium Chewable Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock